| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.012 | 0.8 |